KYMR earnings: a negative outcome, -15.1%

On May 4, 2023, Kymera Therapeutics, Inc. reached its earnings. The result was a negative outcome, and the stock moved -15.1% in the window around the event. It had already run +5.6% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.